

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 5.01780299 |
| 2 | purine nucleobase biosynthetic process (GO:0009113) | 4.50402243 |
| 3 | nucleobase biosynthetic process (GO:0046112) | 4.40803455 |
| 4 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.25405364 |
| 5 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 4.23072696 |
| 6 | folic acid metabolic process (GO:0046655) | 4.06756120 |
| 7 | glycine metabolic process (GO:0006544) | 3.95440323 |
| 8 | maturation of SSU-rRNA (GO:0030490) | 3.86410537 |
| 9 | formation of translation preinitiation complex (GO:0001731) | 3.81595892 |
| 10 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.72968483 |
| 11 | DNA replication initiation (GO:0006270) | 3.66988399 |
| 12 | ribosome assembly (GO:0042255) | 3.62508429 |
| 13 | DNA unwinding involved in DNA replication (GO:0006268) | 3.59195075 |
| 14 | DNA strand elongation (GO:0022616) | 3.55573017 |
| 15 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.53388159 |
| 16 | IMP metabolic process (GO:0046040) | 3.52449974 |
| 17 | translational termination (GO:0006415) | 3.50457766 |
| 18 | viral transcription (GO:0019083) | 3.48801734 |
| 19 | ribosome biogenesis (GO:0042254) | 3.48615200 |
| 20 | ribosomal small subunit assembly (GO:0000028) | 3.47347500 |
| 21 | IMP biosynthetic process (GO:0006188) | 3.43677187 |
| 22 | ribosomal large subunit biogenesis (GO:0042273) | 3.33051427 |
| 23 | translational elongation (GO:0006414) | 3.31888631 |
| 24 | pteridine-containing compound biosynthetic process (GO:0042559) | 3.31808763 |
| 25 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.29213482 |
| 26 | proteasome assembly (GO:0043248) | 3.28965412 |
| 27 | DNA replication checkpoint (GO:0000076) | 3.26486516 |
| 28 | regulation of mitochondrial translation (GO:0070129) | 3.24123107 |
| 29 | translational initiation (GO:0006413) | 3.21585876 |
| 30 | serine family amino acid biosynthetic process (GO:0009070) | 3.20319575 |
| 31 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.19176413 |
| 32 | establishment of integrated proviral latency (GO:0075713) | 3.11756272 |
| 33 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.11043276 |
| 34 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.10671980 |
| 35 | mitotic metaphase plate congression (GO:0007080) | 3.08605627 |
| 36 | ribosomal small subunit biogenesis (GO:0042274) | 3.07330747 |
| 37 | deoxyribonucleotide catabolic process (GO:0009264) | 3.04909221 |
| 38 | serine family amino acid metabolic process (GO:0009069) | 3.04596372 |
| 39 | protein localization to kinetochore (GO:0034501) | 3.02682964 |
| 40 | amino acid salvage (GO:0043102) | 3.02067332 |
| 41 | L-methionine salvage (GO:0071267) | 3.02067332 |
| 42 | L-methionine biosynthetic process (GO:0071265) | 3.02067332 |
| 43 | histone arginine methylation (GO:0034969) | 2.98736167 |
| 44 | pentose-phosphate shunt (GO:0006098) | 2.96582354 |
| 45 | establishment of viral latency (GO:0019043) | 2.96184188 |
| 46 | deoxyribose phosphate catabolic process (GO:0046386) | 2.94293376 |
| 47 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.92927251 |
| 48 | rRNA transcription (GO:0009303) | 2.91763783 |
| 49 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.91497464 |
| 50 | serine family amino acid catabolic process (GO:0009071) | 2.89952400 |
| 51 | regulation of translational termination (GO:0006449) | 2.89804615 |
| 52 | mitotic nuclear envelope disassembly (GO:0007077) | 2.89214153 |
| 53 | L-serine metabolic process (GO:0006563) | 2.88935177 |
| 54 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.87763294 |
| 55 | spliceosomal snRNP assembly (GO:0000387) | 2.86999698 |
| 56 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.86329736 |
| 57 | pseudouridine synthesis (GO:0001522) | 2.85933414 |
| 58 | rRNA processing (GO:0006364) | 2.85484996 |
| 59 | base-excision repair (GO:0006284) | 2.84480801 |
| 60 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.84240662 |
| 61 | L-phenylalanine metabolic process (GO:0006558) | 2.83877730 |
| 62 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.83877730 |
| 63 | sulfur amino acid biosynthetic process (GO:0000097) | 2.83856506 |
| 64 | tetrahydrofolate metabolic process (GO:0046653) | 2.83629853 |
| 65 | peptidyl-arginine N-methylation (GO:0035246) | 2.83595094 |
| 66 | peptidyl-arginine methylation (GO:0018216) | 2.83595094 |
| 67 | folic acid-containing compound metabolic process (GO:0006760) | 2.83248194 |
| 68 | tRNA methylation (GO:0030488) | 2.83222578 |
| 69 | base-excision repair, AP site formation (GO:0006285) | 2.82466938 |
| 70 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.81555911 |
| 71 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.81074096 |
| 72 | one-carbon metabolic process (GO:0006730) | 2.80849168 |
| 73 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.80446443 |
| 74 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.80309169 |
| 75 | viral mRNA export from host cell nucleus (GO:0046784) | 2.79597525 |
| 76 | cotranslational protein targeting to membrane (GO:0006613) | 2.78316000 |
| 77 | protein targeting to ER (GO:0045047) | 2.78049117 |
| 78 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.77071788 |
| 79 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.75800278 |
| 80 | negative regulation of B cell apoptotic process (GO:0002903) | 2.75229587 |
| 81 | mitotic recombination (GO:0006312) | 2.74950258 |
| 82 | rRNA metabolic process (GO:0016072) | 2.74462354 |
| 83 | cysteine metabolic process (GO:0006534) | 2.74426356 |
| 84 | cellular protein complex disassembly (GO:0043624) | 2.74036690 |
| 85 | aspartate family amino acid biosynthetic process (GO:0009067) | 2.72978361 |
| 86 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.72871052 |
| 87 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.72871052 |
| 88 | methionine metabolic process (GO:0006555) | 2.72605084 |
| 89 | mitochondrial fusion (GO:0008053) | 2.72301627 |
| 90 | telomere maintenance via recombination (GO:0000722) | 2.72290412 |
| 91 | mitochondrial RNA metabolic process (GO:0000959) | 2.71393733 |
| 92 | viral life cycle (GO:0019058) | 2.70621292 |
| 93 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.70263380 |
| 94 | rRNA modification (GO:0000154) | 2.68308056 |
| 95 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.68221992 |
| 96 | negative regulation of ligase activity (GO:0051352) | 2.68221992 |
| 97 | protein localization to endoplasmic reticulum (GO:0070972) | 2.67959892 |
| 98 | NADPH regeneration (GO:0006740) | 2.67682996 |
| 99 | negative regulation of mRNA processing (GO:0050686) | 2.66339136 |
| 100 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.65666031 |
| 101 | nuclear envelope disassembly (GO:0051081) | 2.65590357 |
| 102 | membrane disassembly (GO:0030397) | 2.65590357 |
| 103 | telomere maintenance via telomere lengthening (GO:0010833) | 2.65198734 |
| 104 | protein maturation by protein folding (GO:0022417) | 2.64367286 |
| 105 | nucleoside salvage (GO:0043174) | 2.64315688 |
| 106 | cellular component biogenesis (GO:0044085) | 2.63915398 |
| 107 | protein targeting to mitochondrion (GO:0006626) | 2.63442583 |
| 108 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.63097334 |
| 109 | pteridine-containing compound metabolic process (GO:0042558) | 2.63086682 |
| 110 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.62893992 |
| 111 | methionine biosynthetic process (GO:0009086) | 2.62822423 |
| 112 | mitotic chromosome condensation (GO:0007076) | 2.62377715 |
| 113 | pentose metabolic process (GO:0019321) | 2.61852718 |
| 114 | kynurenine metabolic process (GO:0070189) | 2.61617924 |
| 115 | immunoglobulin mediated immune response (GO:0016064) | 2.61581628 |
| 116 | negative regulation of RNA splicing (GO:0033119) | 2.60665240 |
| 117 | chaperone-mediated protein transport (GO:0072321) | 2.60377257 |
| 118 | transcription from mitochondrial promoter (GO:0006390) | 2.59973506 |
| 119 | AMP metabolic process (GO:0046033) | 2.59971880 |
| 120 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.59460628 |
| 121 | translation (GO:0006412) | 2.59349861 |
| 122 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.58805436 |
| 123 | pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173) | 2.58012539 |
| 124 | UMP biosynthetic process (GO:0006222) | 2.58012539 |
| 125 | pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174) | 2.58012539 |
| 126 | UMP metabolic process (GO:0046049) | 2.58012539 |
| 127 | iron-sulfur cluster assembly (GO:0016226) | 2.57315541 |
| 128 | metallo-sulfur cluster assembly (GO:0031163) | 2.57315541 |
| 129 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.56433197 |
| 130 | purine nucleobase metabolic process (GO:0006144) | 2.56223491 |
| 131 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.54550131 |
| 132 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.53664313 |
| 133 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.53664313 |
| 134 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.53319458 |
| 135 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.53186478 |
| 136 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.53071706 |
| 137 | oxidative phosphorylation (GO:0006119) | 2.52583757 |
| 138 | urea cycle (GO:0000050) | 2.52520380 |
| 139 | urea metabolic process (GO:0019627) | 2.52520380 |
| 140 | 2-deoxyribonucleotide metabolic process (GO:0009394) | 2.52321021 |
| 141 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.52317049 |
| 142 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.52112342 |
| 143 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.52112342 |
| 144 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.51760719 |
| 145 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.51760719 |
| 146 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.51730411 |
| 147 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.51730411 |
| 148 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.51730411 |
| 149 | nucleotide salvage (GO:0043173) | 2.51623628 |
| 150 | L-phenylalanine catabolic process (GO:0006559) | 2.51439854 |
| 151 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.51439854 |
| 152 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.49659233 |
| 153 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.48845480 |
| 154 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.46209479 |
| 155 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.46070991 |
| 156 | GDP-mannose metabolic process (GO:0019673) | 2.45292627 |
| 157 | deoxyribose phosphate metabolic process (GO:0019692) | 2.43161692 |
| 158 | B cell mediated immunity (GO:0019724) | 2.42660785 |
| 159 | DNA ligation (GO:0006266) | 2.41920141 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.63058684 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.96902937 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.83109954 |
| 4 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.92292883 |
| 5 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.87100868 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.79915053 |
| 7 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.76714878 |
| 8 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.73990166 |
| 9 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.69648344 |
| 10 | * EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.59541436 |
| 11 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.51968625 |
| 12 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.49500216 |
| 13 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.49036496 |
| 14 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.39512702 |
| 15 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.38840655 |
| 16 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.27646156 |
| 17 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.19047952 |
| 18 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.11241121 |
| 19 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.08772395 |
| 20 | * VDR_23849224_ChIP-Seq_CD4+_Human | 2.05677376 |
| 21 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.02571179 |
| 22 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.01662649 |
| 23 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.93696809 |
| 24 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.91761098 |
| 25 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.90993728 |
| 26 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.90728899 |
| 27 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.89127857 |
| 28 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.88758634 |
| 29 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.87922643 |
| 30 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.78341181 |
| 31 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.74646567 |
| 32 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.74235609 |
| 33 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.73517881 |
| 34 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.73203110 |
| 35 | MYC_22102868_ChIP-Seq_BL_Human | 1.73143456 |
| 36 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.71696617 |
| 37 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.65993597 |
| 38 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.61973240 |
| 39 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.61430315 |
| 40 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.59531187 |
| 41 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.58436870 |
| 42 | * ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.57669102 |
| 43 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.56701506 |
| 44 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55297600 |
| 45 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.54195275 |
| 46 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.52614448 |
| 47 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.51415775 |
| 48 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.49495514 |
| 49 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.48743067 |
| 50 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.48370486 |
| 51 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.46964312 |
| 52 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.46269475 |
| 53 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.43924385 |
| 54 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.41786911 |
| 55 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.40748702 |
| 56 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.40514706 |
| 57 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.36883138 |
| 58 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.35134665 |
| 59 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.34367458 |
| 60 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.34364021 |
| 61 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.34202506 |
| 62 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.32831916 |
| 63 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.32128718 |
| 64 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.28832132 |
| 65 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.27737812 |
| 66 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.27377155 |
| 67 | MAF_26560356_Chip-Seq_TH1_Human | 1.26942633 |
| 68 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26820667 |
| 69 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.25065163 |
| 70 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.23768321 |
| 71 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.23583337 |
| 72 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.20873837 |
| 73 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20768358 |
| 74 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.20448275 |
| 75 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.19921222 |
| 76 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.19618150 |
| 77 | UTX_26944678_Chip-Seq_JUKART_Human | 1.19023932 |
| 78 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.17739853 |
| 79 | MAF_26560356_Chip-Seq_TH2_Human | 1.16347022 |
| 80 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.15607912 |
| 81 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.14348139 |
| 82 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.14311035 |
| 83 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12105735 |
| 84 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.11108594 |
| 85 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.10186247 |
| 86 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.09899000 |
| 87 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.08868581 |
| 88 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.08007764 |
| 89 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.07627540 |
| 90 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.05650463 |
| 91 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.05449547 |
| 92 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.05186903 |
| 93 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.02771738 |
| 94 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.02473291 |
| 95 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.01673044 |
| 96 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01033517 |
| 97 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.01024406 |
| 98 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.00991094 |
| 99 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.00068743 |
| 100 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.00018786 |
| 101 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.99513445 |
| 102 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.99440934 |
| 103 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.99031364 |
| 104 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.98802858 |
| 105 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.97679771 |
| 106 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.95692686 |
| 107 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.95222983 |
| 108 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.94001208 |
| 109 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.92192220 |
| 110 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.91976864 |
| 111 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.91784301 |
| 112 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.91729384 |
| 113 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.91606932 |
| 114 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.88887444 |
| 115 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.86891908 |
| 116 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.83787716 |
| 117 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.83188712 |
| 118 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.82980827 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 4.10565133 |
| 2 | MP0003693_abnormal_embryo_hatching | 3.90441020 |
| 3 | MP0009840_abnormal_foam_cell | 3.44692909 |
| 4 | MP0005360_urolithiasis | 3.21194756 |
| 5 | MP0002139_abnormal_hepatobiliary_system | 3.11887862 |
| 6 | MP0004957_abnormal_blastocyst_morpholog | 3.06904964 |
| 7 | MP0003111_abnormal_nucleus_morphology | 2.91128530 |
| 8 | MP0010094_abnormal_chromosome_stability | 2.84068658 |
| 9 | MP0005365_abnormal_bile_salt | 2.65140621 |
| 10 | MP0009278_abnormal_bone_marrow | 2.54465714 |
| 11 | MP0005085_abnormal_gallbladder_physiolo | 2.53703906 |
| 12 | MP0003077_abnormal_cell_cycle | 2.48483582 |
| 13 | MP0008875_abnormal_xenobiotic_pharmacok | 2.06521132 |
| 14 | MP0003718_maternal_effect | 2.03778505 |
| 15 | MP0008057_abnormal_DNA_replication | 2.01842865 |
| 16 | MP0008058_abnormal_DNA_repair | 1.91697845 |
| 17 | MP0003646_muscle_fatigue | 1.89523260 |
| 18 | MP0003786_premature_aging | 1.88602145 |
| 19 | MP0002396_abnormal_hematopoietic_system | 1.85763651 |
| 20 | MP0003186_abnormal_redox_activity | 1.84104550 |
| 21 | MP0010329_abnormal_lipoprotein_level | 1.79885494 |
| 22 | MP0008260_abnormal_autophagy | 1.79746226 |
| 23 | MP0003191_abnormal_cellular_cholesterol | 1.77995617 |
| 24 | MP0006036_abnormal_mitochondrial_physio | 1.74006894 |
| 25 | MP0003656_abnormal_erythrocyte_physiolo | 1.70061931 |
| 26 | MP0001730_embryonic_growth_arrest | 1.67109352 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 1.65133026 |
| 28 | MP0003303_peritoneal_inflammation | 1.63999757 |
| 29 | MP0001764_abnormal_homeostasis | 1.61845858 |
| 30 | MP0000609_abnormal_liver_physiology | 1.59531165 |
| 31 | MP0008932_abnormal_embryonic_tissue | 1.56956517 |
| 32 | MP0001790_abnormal_immune_system | 1.56111549 |
| 33 | MP0005387_immune_system_phenotype | 1.56111549 |
| 34 | MP0003011_delayed_dark_adaptation | 1.53384781 |
| 35 | MP0005332_abnormal_amino_acid | 1.52810869 |
| 36 | MP0006035_abnormal_mitochondrial_morpho | 1.52291660 |
| 37 | MP0002148_abnormal_hypersensitivity_rea | 1.50385610 |
| 38 | MP0003763_abnormal_thymus_physiology | 1.44404805 |
| 39 | MP0001835_abnormal_antigen_presentation | 1.39790004 |
| 40 | MP0010352_gastrointestinal_tract_polyps | 1.38531382 |
| 41 | MP0008007_abnormal_cellular_replicative | 1.38521975 |
| 42 | MP0002019_abnormal_tumor_incidence | 1.38385341 |
| 43 | MP0000358_abnormal_cell_content/ | 1.37320020 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.37305949 |
| 45 | MP0005319_abnormal_enzyme/_coenzyme | 1.34951300 |
| 46 | MP0000350_abnormal_cell_proliferation | 1.34473993 |
| 47 | MP0010307_abnormal_tumor_latency | 1.34401992 |
| 48 | MP0003436_decreased_susceptibility_to | 1.33762691 |
| 49 | MP0004808_abnormal_hematopoietic_stem | 1.31097347 |
| 50 | MP0000598_abnormal_liver_morphology | 1.31090728 |
| 51 | MP0000490_abnormal_crypts_of | 1.29313825 |
| 52 | MP0004233_abnormal_muscle_weight | 1.25885030 |
| 53 | MP0002722_abnormal_immune_system | 1.25361517 |
| 54 | MP0005397_hematopoietic_system_phenotyp | 1.24627780 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.24627780 |
| 56 | MP0000465_gastrointestinal_hemorrhage | 1.23688968 |
| 57 | MP0009785_altered_susceptibility_to | 1.23014401 |
| 58 | MP0002398_abnormal_bone_marrow | 1.22147372 |
| 59 | MP0005083_abnormal_biliary_tract | 1.18406540 |
| 60 | MP0005310_abnormal_salivary_gland | 1.17232176 |
| 61 | MP0005058_abnormal_lysosome_morphology | 1.16962108 |
| 62 | MP0003221_abnormal_cardiomyocyte_apopto | 1.15583784 |
| 63 | MP0008469_abnormal_protein_level | 1.14746912 |
| 64 | MP0005451_abnormal_body_composition | 1.13662712 |
| 65 | MP0002132_abnormal_respiratory_system | 1.12674713 |
| 66 | MP0005266_abnormal_metabolism | 1.11268901 |
| 67 | MP0005501_abnormal_skin_physiology | 1.10413961 |
| 68 | MP0000858_altered_metastatic_potential | 1.08288500 |
| 69 | MP0001800_abnormal_humoral_immune | 1.08056869 |
| 70 | MP0005025_abnormal_response_to | 1.07260238 |
| 71 | MP0002429_abnormal_blood_cell | 1.06932503 |
| 72 | MP0002080_prenatal_lethality | 1.05986824 |
| 73 | MP0001727_abnormal_embryo_implantation | 1.05973563 |
| 74 | MP0000685_abnormal_immune_system | 1.03344385 |
| 75 | MP0005671_abnormal_response_to | 1.03187030 |
| 76 | MP0005464_abnormal_platelet_physiology | 1.03049295 |
| 77 | MP0002723_abnormal_immune_serum | 1.02671352 |
| 78 | MP0000716_abnormal_immune_system | 1.00314070 |
| 79 | MP0000313_abnormal_cell_death | 1.00216431 |
| 80 | MP0001672_abnormal_embryogenesis/_devel | 1.00207708 |
| 81 | MP0005380_embryogenesis_phenotype | 1.00207708 |
| 82 | MP0001697_abnormal_embryo_size | 0.99290253 |
| 83 | MP0002163_abnormal_gland_morphology | 0.99116690 |
| 84 | MP0001853_heart_inflammation | 0.99111871 |
| 85 | MP0003705_abnormal_hypodermis_morpholog | 0.98891049 |
| 86 | MP0005670_abnormal_white_adipose | 0.98414186 |
| 87 | MP0002420_abnormal_adaptive_immunity | 0.97311960 |
| 88 | MP0001666_abnormal_nutrient_absorption | 0.97001201 |
| 89 | MP0001873_stomach_inflammation | 0.96731791 |
| 90 | MP0002405_respiratory_system_inflammati | 0.96389782 |
| 91 | MP0003123_paternal_imprinting | 0.96339375 |
| 92 | MP0001819_abnormal_immune_cell | 0.96093117 |
| 93 | MP0000703_abnormal_thymus_morphology | 0.95362903 |
| 94 | MP0002452_abnormal_antigen_presenting | 0.93776174 |
| 95 | MP0002277_abnormal_respiratory_mucosa | 0.93590227 |
| 96 | MP0001845_abnormal_inflammatory_respons | 0.92635799 |
| 97 | MP0008873_increased_physiological_sensi | 0.91692084 |
| 98 | MP0006082_CNS_inflammation | 0.91632699 |
| 99 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.91021012 |
| 100 | MP0005000_abnormal_immune_tolerance | 0.90277024 |
| 101 | MP0003984_embryonic_growth_retardation | 0.89833362 |
| 102 | MP0002419_abnormal_innate_immunity | 0.89678336 |
| 103 | MP0009763_increased_sensitivity_to | 0.89415595 |
| 104 | MP0002796_impaired_skin_barrier | 0.87980406 |
| 105 | MP0001881_abnormal_mammary_gland | 0.87657349 |
| 106 | MP0002088_abnormal_embryonic_growth/wei | 0.87037125 |
| 107 | MP0002118_abnormal_lipid_homeostasis | 0.85827541 |
| 108 | MP0001661_extended_life_span | 0.84308680 |
| 109 | MP0004019_abnormal_vitamin_homeostasis | 0.82676966 |
| 110 | MP0005376_homeostasis/metabolism_phenot | 0.82669456 |
| 111 | MP0009672_abnormal_birth_weight | 0.82311481 |
| 112 | MP0005384_cellular_phenotype | 0.82141548 |
| 113 | MP0001915_intracranial_hemorrhage | 0.81984818 |
| 114 | MP0002269_muscular_atrophy | 0.81929252 |
| 115 | MP0001346_abnormal_lacrimal_gland | 0.80952463 |
| 116 | MP0005395_other_phenotype | 0.80501128 |
| 117 | MP0005621_abnormal_cell_physiology | 0.80149952 |
| 118 | MP0000015_abnormal_ear_pigmentation | 0.80105642 |
| 119 | MP0005023_abnormal_wound_healing | 0.79953039 |
| 120 | MP0009643_abnormal_urine_homeostasis | 0.78970953 |
| 121 | MP0004947_skin_inflammation | 0.78870727 |
| 122 | MP0003172_abnormal_lysosome_physiology | 0.76969109 |
| 123 | MP0004185_abnormal_adipocyte_glucose | 0.76681705 |
| 124 | MP0001348_abnormal_lacrimal_gland | 0.75320700 |
| 125 | MP0003075_altered_response_to | 0.73806985 |
| 126 | MP0005075_abnormal_melanosome_morpholog | 0.73334814 |
| 127 | MP0010155_abnormal_intestine_physiology | 0.72717026 |
| 128 | MP0003866_abnormal_defecation | 0.72356896 |
| 129 | MP0008995_early_reproductive_senescence | 0.72316641 |
| 130 | MP0002166_altered_tumor_susceptibility | 0.70324411 |
| 131 | MP0000681_abnormal_thyroid_gland | 0.66840416 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypobetalipoproteinemia (HP:0003563) | 4.44928192 |
| 2 | Microvesicular hepatic steatosis (HP:0001414) | 4.38306946 |
| 3 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.92170678 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.89613085 |
| 5 | Abnormal number of erythroid precursors (HP:0012131) | 3.79524395 |
| 6 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.45465126 |
| 7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.37998696 |
| 8 | Multiple enchondromatosis (HP:0005701) | 3.27169043 |
| 9 | Oral leukoplakia (HP:0002745) | 3.25529249 |
| 10 | Reticulocytopenia (HP:0001896) | 3.24928231 |
| 11 | Deep venous thrombosis (HP:0002625) | 3.23708286 |
| 12 | Hypertensive crisis (HP:0100735) | 3.15502784 |
| 13 | Birth length less than 3rd percentile (HP:0003561) | 3.13013923 |
| 14 | Increased intramyocellular lipid droplets (HP:0012240) | 3.05905673 |
| 15 | Xanthomatosis (HP:0000991) | 3.04528375 |
| 16 | Hypolipoproteinemia (HP:0010981) | 3.03592449 |
| 17 | Intrahepatic cholestasis (HP:0001406) | 2.88912851 |
| 18 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.87591184 |
| 19 | Hyperammonemia (HP:0001987) | 2.86619343 |
| 20 | Abnormality of methionine metabolism (HP:0010901) | 2.85628987 |
| 21 | Premature ovarian failure (HP:0008209) | 2.84057780 |
| 22 | Hyperglycinemia (HP:0002154) | 2.76186398 |
| 23 | Chronic obstructive pulmonary disease (HP:0006510) | 2.74068299 |
| 24 | Obstructive lung disease (HP:0006536) | 2.74068299 |
| 25 | Progressive external ophthalmoplegia (HP:0000590) | 2.72838895 |
| 26 | Hyperlipoproteinemia (HP:0010980) | 2.71686486 |
| 27 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.70849577 |
| 28 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.70849577 |
| 29 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.70753567 |
| 30 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.67492445 |
| 31 | Abnormality of serum amino acid levels (HP:0003112) | 2.63628517 |
| 32 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.63528673 |
| 33 | Spastic diplegia (HP:0001264) | 2.62097248 |
| 34 | Hyperglycinuria (HP:0003108) | 2.57654943 |
| 35 | Cholecystitis (HP:0001082) | 2.57038134 |
| 36 | Abnormal gallbladder physiology (HP:0012438) | 2.57038134 |
| 37 | Macrocytic anemia (HP:0001972) | 2.52094456 |
| 38 | Mediastinal lymphadenopathy (HP:0100721) | 2.51311856 |
| 39 | Microretrognathia (HP:0000308) | 2.50712991 |
| 40 | Breast hypoplasia (HP:0003187) | 2.49847621 |
| 41 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.48953713 |
| 42 | Abnormality of alanine metabolism (HP:0010916) | 2.48953713 |
| 43 | Hyperalaninemia (HP:0003348) | 2.48953713 |
| 44 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.47998359 |
| 45 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.47618335 |
| 46 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.47115645 |
| 47 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.44754652 |
| 48 | Aplastic anemia (HP:0001915) | 2.44150619 |
| 49 | Agammaglobulinemia (HP:0004432) | 2.42306777 |
| 50 | Recurrent viral infections (HP:0004429) | 2.42152293 |
| 51 | Hepatosplenomegaly (HP:0001433) | 2.40263143 |
| 52 | Respiratory difficulties (HP:0002880) | 2.39153479 |
| 53 | Degeneration of anterior horn cells (HP:0002398) | 2.38459381 |
| 54 | Abnormality of the anterior horn cell (HP:0006802) | 2.38459381 |
| 55 | Pallor (HP:0000980) | 2.37105303 |
| 56 | Brushfield spots (HP:0001088) | 2.36698001 |
| 57 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.36586919 |
| 58 | Cerebral edema (HP:0002181) | 2.33678249 |
| 59 | Type I transferrin isoform profile (HP:0003642) | 2.33189146 |
| 60 | Recurrent abscess formation (HP:0002722) | 2.32516881 |
| 61 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.31864263 |
| 62 | Abnormality of glycine metabolism (HP:0010895) | 2.31864263 |
| 63 | Seborrheic dermatitis (HP:0001051) | 2.31788638 |
| 64 | Agnosia (HP:0010524) | 2.31191812 |
| 65 | Cerebral hypomyelination (HP:0006808) | 2.30672794 |
| 66 | Rhabdomyolysis (HP:0003201) | 2.30400942 |
| 67 | Increased CSF lactate (HP:0002490) | 2.29755029 |
| 68 | Chronic otitis media (HP:0000389) | 2.28841397 |
| 69 | Increased serum ferritin (HP:0003281) | 2.28134340 |
| 70 | Recurrent bacterial skin infections (HP:0005406) | 2.27967654 |
| 71 | Hepatic necrosis (HP:0002605) | 2.27268895 |
| 72 | Mitochondrial inheritance (HP:0001427) | 2.26766510 |
| 73 | Reduced antithrombin III activity (HP:0001976) | 2.26495873 |
| 74 | Squamous cell carcinoma (HP:0002860) | 2.23083135 |
| 75 | Abnormality of the common coagulation pathway (HP:0010990) | 2.22483390 |
| 76 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.22446015 |
| 77 | IgM deficiency (HP:0002850) | 2.22100775 |
| 78 | Acute necrotizing encephalopathy (HP:0006965) | 2.21886118 |
| 79 | Hepatocellular necrosis (HP:0001404) | 2.21833527 |
| 80 | Cleft eyelid (HP:0000625) | 2.21525494 |
| 81 | Cellulitis (HP:0100658) | 2.21375868 |
| 82 | Exercise intolerance (HP:0003546) | 2.21205470 |
| 83 | Abnormal trabecular bone morphology (HP:0100671) | 2.20783396 |
| 84 | Prolonged partial thromboplastin time (HP:0003645) | 2.20601388 |
| 85 | Panhypogammaglobulinemia (HP:0003139) | 2.20413186 |
| 86 | Increased serum lactate (HP:0002151) | 2.18412010 |
| 87 | Combined immunodeficiency (HP:0005387) | 2.17072313 |
| 88 | Truncus arteriosus (HP:0001660) | 2.16985156 |
| 89 | Progressive muscle weakness (HP:0003323) | 2.16793855 |
| 90 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.16634818 |
| 91 | Lethargy (HP:0001254) | 2.15599237 |
| 92 | Abnormality of iron homeostasis (HP:0011031) | 2.15499997 |
| 93 | Cellular immunodeficiency (HP:0005374) | 2.13876087 |
| 94 | Hypoalphalipoproteinemia (HP:0003233) | 2.13079640 |
| 95 | Abnormality of reticulocytes (HP:0004312) | 2.11999763 |
| 96 | Thrombocytosis (HP:0001894) | 2.10788804 |
| 97 | Lymphopenia (HP:0001888) | 2.10680567 |
| 98 | Rough bone trabeculation (HP:0100670) | 2.10134790 |
| 99 | Abnormal protein glycosylation (HP:0012346) | 2.10002898 |
| 100 | Abnormal glycosylation (HP:0012345) | 2.10002898 |
| 101 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.10002898 |
| 102 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.10002898 |
| 103 | Recurrent fungal infections (HP:0002841) | 2.10002091 |
| 104 | CNS demyelination (HP:0007305) | 2.09738416 |
| 105 | Increased IgM level (HP:0003496) | 2.09711497 |
| 106 | Ragged-red muscle fibers (HP:0003200) | 2.06472720 |
| 107 | Abnormality of nucleobase metabolism (HP:0010932) | 2.05653502 |
| 108 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.05302167 |
| 109 | Stomatitis (HP:0010280) | 2.05169713 |
| 110 | IgA deficiency (HP:0002720) | 2.02022585 |
| 111 | Chromsome breakage (HP:0040012) | 2.01740458 |
| 112 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.01637635 |
| 113 | Secondary amenorrhea (HP:0000869) | 2.00064936 |
| 114 | Hypergonadotropic hypogonadism (HP:0000815) | 1.99452474 |
| 115 | Impaired proprioception (HP:0010831) | 1.99181962 |
| 116 | Complement deficiency (HP:0004431) | 1.97654156 |
| 117 | Nausea (HP:0002018) | 1.96251766 |
| 118 | Meningitis (HP:0001287) | 1.96058515 |
| 119 | Increased serum pyruvate (HP:0003542) | 1.95736135 |
| 120 | Abnormality of glycolysis (HP:0004366) | 1.95736135 |
| 121 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.94455757 |
| 122 | Dicarboxylic aciduria (HP:0003215) | 1.94455757 |
| 123 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.93645065 |
| 124 | Abnormal cartilage morphology (HP:0002763) | 1.92517503 |
| 125 | Severe combined immunodeficiency (HP:0004430) | 1.92439450 |
| 126 | Abnormality of the motor neurons (HP:0002450) | 1.92287510 |
| 127 | Abnormal neuron morphology (HP:0012757) | 1.92287510 |
| 128 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.91945112 |
| 129 | Epidermoid cyst (HP:0200040) | 1.91413497 |
| 130 | Fatigue (HP:0012378) | 1.90845825 |
| 131 | Acute encephalopathy (HP:0006846) | 1.89993251 |
| 132 | Lactic acidosis (HP:0003128) | 1.89272593 |
| 133 | Eczematoid dermatitis (HP:0000976) | 1.89081938 |
| 134 | Gastrointestinal stroma tumor (HP:0100723) | 1.88765444 |
| 135 | Abnormality of lateral ventricle (HP:0030047) | 1.88536013 |
| 136 | Acute hepatic failure (HP:0006554) | 1.85538345 |
| 137 | Urticaria (HP:0001025) | 1.84500950 |
| 138 | Bone marrow hypocellularity (HP:0005528) | 1.84478325 |
| 139 | Lymphoma (HP:0002665) | 1.83625961 |
| 140 | Global brain atrophy (HP:0002283) | 1.83467217 |
| 141 | Megaloblastic anemia (HP:0001889) | 1.83164602 |
| 142 | Pancytopenia (HP:0001876) | 1.82706460 |
| 143 | Abnormality of complement system (HP:0005339) | 1.80456654 |
| 144 | Absent thumb (HP:0009777) | 1.79721410 |
| 145 | Patellar aplasia (HP:0006443) | 1.79639008 |
| 146 | Hyperbilirubinemia (HP:0002904) | 1.79295244 |
| 147 | Increased muscle lipid content (HP:0009058) | 1.79192603 |
| 148 | Death in infancy (HP:0001522) | 1.78023452 |
| 149 | Acanthocytosis (HP:0001927) | 1.77662096 |
| 150 | 3-Methylglutaconic aciduria (HP:0003535) | 1.77458564 |
| 151 | Pustule (HP:0200039) | 1.77233166 |
| 152 | Upper motor neuron abnormality (HP:0002127) | 1.76842672 |
| 153 | Ketosis (HP:0001946) | 1.76618975 |
| 154 | Abnormality of the preputium (HP:0100587) | 1.75536052 |
| 155 | Petechiae (HP:0000967) | 1.75008382 |
| 156 | Abnormality of the intrinsic pathway (HP:0010989) | 1.74648156 |
| 157 | Abnormality of macrophages (HP:0004311) | 1.74392782 |
| 158 | CNS hypomyelination (HP:0003429) | 1.74127501 |
| 159 | Spastic paraparesis (HP:0002313) | 1.72515040 |
| 160 | Abnormality of T cell physiology (HP:0011840) | 1.71614171 |
| 161 | Trismus (HP:0000211) | 1.71252161 |
| 162 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.70089865 |
| 163 | Carpal bone hypoplasia (HP:0001498) | 1.69989797 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 4.18189316 |
| 2 | NME2 | 3.69175689 |
| 3 | VRK2 | 3.32426745 |
| 4 | WEE1 | 3.20238394 |
| 5 | BCKDK | 2.95669705 |
| 6 | SMG1 | 2.91385041 |
| 7 | CDC7 | 2.49726001 |
| 8 | EIF2AK1 | 2.49673798 |
| 9 | FLT3 | 2.24104663 |
| 10 | NEK2 | 2.07328901 |
| 11 | MAP4K1 | 2.07124628 |
| 12 | TESK2 | 2.05734851 |
| 13 | SCYL2 | 2.05420997 |
| 14 | BRAF | 1.89717195 |
| 15 | TSSK6 | 1.84586498 |
| 16 | NEK1 | 1.83373159 |
| 17 | PRPF4B | 1.82686208 |
| 18 | PKN2 | 1.80309576 |
| 19 | ACVR1B | 1.75454876 |
| 20 | MAP3K11 | 1.73370882 |
| 21 | EIF2AK3 | 1.72745016 |
| 22 | KDR | 1.70582998 |
| 23 | ZAK | 1.70540522 |
| 24 | TRIB3 | 1.69288466 |
| 25 | RPS6KA4 | 1.63707978 |
| 26 | STK16 | 1.56353821 |
| 27 | TTK | 1.50661666 |
| 28 | RPS6KB2 | 1.48132176 |
| 29 | MAP3K8 | 1.47565851 |
| 30 | STK10 | 1.41634924 |
| 31 | CCNB1 | 1.41103577 |
| 32 | EEF2K | 1.39466569 |
| 33 | TYK2 | 1.38771591 |
| 34 | AKT3 | 1.36784397 |
| 35 | BRSK2 | 1.31526112 |
| 36 | ZAP70 | 1.29849321 |
| 37 | LRRK2 | 1.23274593 |
| 38 | PLK1 | 1.21576576 |
| 39 | ERN1 | 1.20805192 |
| 40 | MAPKAPK3 | 1.20589578 |
| 41 | CDK12 | 1.20033099 |
| 42 | PDK2 | 1.17758849 |
| 43 | TEC | 1.16547374 |
| 44 | TAOK2 | 1.13743033 |
| 45 | IRAK4 | 1.11719975 |
| 46 | PLK4 | 1.10569805 |
| 47 | CDK4 | 1.10221733 |
| 48 | TBK1 | 1.09793563 |
| 49 | PIM2 | 1.09625872 |
| 50 | IKBKB | 1.09092615 |
| 51 | PBK | 1.08883225 |
| 52 | DYRK3 | 1.08757591 |
| 53 | VRK1 | 1.08084205 |
| 54 | MAP2K3 | 1.08029797 |
| 55 | GRK6 | 1.06764446 |
| 56 | TAOK3 | 1.06541064 |
| 57 | AURKA | 1.06534590 |
| 58 | AURKB | 1.06515047 |
| 59 | ARAF | 1.05997786 |
| 60 | KIT | 1.05900181 |
| 61 | MAP3K13 | 1.04234837 |
| 62 | RIPK4 | 1.00183047 |
| 63 | MAP3K14 | 0.98957295 |
| 64 | PASK | 0.98565812 |
| 65 | NME1 | 0.98075896 |
| 66 | TNK2 | 0.96234147 |
| 67 | FGFR4 | 0.93552339 |
| 68 | CDK7 | 0.93369348 |
| 69 | PDK4 | 0.91027465 |
| 70 | PDK3 | 0.91027465 |
| 71 | BRSK1 | 0.85729515 |
| 72 | MAP3K10 | 0.83890041 |
| 73 | PIM1 | 0.82877565 |
| 74 | CHEK2 | 0.82280296 |
| 75 | TGFBR1 | 0.78956658 |
| 76 | BTK | 0.78828121 |
| 77 | RPS6KA5 | 0.78308477 |
| 78 | EPHA2 | 0.76620150 |
| 79 | BMX | 0.75114584 |
| 80 | TLK1 | 0.74420093 |
| 81 | CSNK1G3 | 0.74002608 |
| 82 | ATR | 0.73928016 |
| 83 | MAP3K5 | 0.71460899 |
| 84 | CDK9 | 0.71194375 |
| 85 | PAK4 | 0.68819248 |
| 86 | TESK1 | 0.68602264 |
| 87 | DAPK1 | 0.66944104 |
| 88 | TAF1 | 0.65211727 |
| 89 | ERBB4 | 0.64629662 |
| 90 | MAPK11 | 0.62807042 |
| 91 | DAPK3 | 0.61540349 |
| 92 | IKBKE | 0.61370569 |
| 93 | FES | 0.60345001 |
| 94 | SYK | 0.60087024 |
| 95 | MAP3K3 | 0.59789671 |
| 96 | MST1R | 0.59677868 |
| 97 | CDK8 | 0.59427816 |
| 98 | MAP3K1 | 0.59404476 |
| 99 | MAP2K2 | 0.59148469 |
| 100 | CDK19 | 0.57775774 |
| 101 | CHEK1 | 0.57753258 |
| 102 | ABL2 | 0.56844233 |
| 103 | CSF1R | 0.55790477 |
| 104 | BLK | 0.54985936 |
| 105 | TAOK1 | 0.53625158 |
| 106 | SIK3 | 0.52570394 |
| 107 | CSNK2A2 | 0.51958767 |
| 108 | RAF1 | 0.51791992 |
| 109 | IRAK3 | 0.51730687 |
| 110 | MOS | 0.51652877 |
| 111 | LATS2 | 0.50798957 |
| 112 | TXK | 0.50627277 |
| 113 | PLK3 | 0.50590198 |
| 114 | JAK3 | 0.50348245 |
| 115 | LYN | 0.49686689 |
| 116 | ITK | 0.49593945 |
| 117 | STK4 | 0.49414977 |
| 118 | MAP2K6 | 0.48945100 |
| 119 | PAK1 | 0.47860355 |
| 120 | CSNK2A1 | 0.46912064 |
| 121 | SRPK1 | 0.46289673 |
| 122 | ALK | 0.46257234 |
| 123 | NUAK1 | 0.45350191 |
| 124 | CSNK1A1L | 0.44745348 |
| 125 | IRAK2 | 0.43088612 |
| 126 | MAP3K6 | 0.39502002 |
| 127 | CDK2 | 0.39089374 |
| 128 | DYRK2 | 0.39035101 |
| 129 | CDK6 | 0.38476434 |
| 130 | AKT2 | 0.35852528 |
| 131 | NEK9 | 0.35564831 |
| 132 | CSNK1G1 | 0.34803483 |
| 133 | ATM | 0.34665193 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.36770421 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.05583550 |
| 3 | Ribosome_Homo sapiens_hsa03010 | 2.81508478 |
| 4 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.49740832 |
| 5 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.47997912 |
| 6 | Mismatch repair_Homo sapiens_hsa03430 | 2.45733218 |
| 7 | RNA polymerase_Homo sapiens_hsa03020 | 2.41321914 |
| 8 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.30468584 |
| 9 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.22620749 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 2.20522683 |
| 11 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.11780579 |
| 12 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.11098884 |
| 13 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 2.08271085 |
| 14 | RNA transport_Homo sapiens_hsa03013 | 2.06074517 |
| 15 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 2.04030662 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.02821833 |
| 17 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.00749194 |
| 18 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.00167637 |
| 19 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.98527145 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.94113490 |
| 21 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.92810584 |
| 22 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.91718801 |
| 23 | Spliceosome_Homo sapiens_hsa03040 | 1.83498122 |
| 24 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.77978016 |
| 25 | Sulfur relay system_Homo sapiens_hsa04122 | 1.72928905 |
| 26 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.70704933 |
| 27 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.62588066 |
| 28 | Carbon metabolism_Homo sapiens_hsa01200 | 1.58546984 |
| 29 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.56145668 |
| 30 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.47366112 |
| 31 | Homologous recombination_Homo sapiens_hsa03440 | 1.41147984 |
| 32 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.39664166 |
| 33 | Cell cycle_Homo sapiens_hsa04110 | 1.34968898 |
| 34 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.33715719 |
| 35 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.23610944 |
| 36 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.23060942 |
| 37 | Allograft rejection_Homo sapiens_hsa05330 | 1.19126727 |
| 38 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.19037764 |
| 39 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.17459634 |
| 40 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.13166843 |
| 41 | Peroxisome_Homo sapiens_hsa04146 | 1.10803373 |
| 42 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.09035757 |
| 43 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.07989874 |
| 44 | Asthma_Homo sapiens_hsa05310 | 1.06696244 |
| 45 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.06660970 |
| 46 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.05196619 |
| 47 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.03485988 |
| 48 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.02972127 |
| 49 | RNA degradation_Homo sapiens_hsa03018 | 1.00243884 |
| 50 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.99494485 |
| 51 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.98538547 |
| 52 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.97602127 |
| 53 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.97247245 |
| 54 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.96760154 |
| 55 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.93672006 |
| 56 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.91406205 |
| 57 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.90449300 |
| 58 | Purine metabolism_Homo sapiens_hsa00230 | 0.89049398 |
| 59 | Leishmaniasis_Homo sapiens_hsa05140 | 0.87980539 |
| 60 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.87446961 |
| 61 | Shigellosis_Homo sapiens_hsa05131 | 0.84983106 |
| 62 | Viral myocarditis_Homo sapiens_hsa05416 | 0.84867218 |
| 63 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.84638282 |
| 64 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.83437768 |
| 65 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.83269264 |
| 66 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.81387514 |
| 67 | Other glycan degradation_Homo sapiens_hsa00511 | 0.80987895 |
| 68 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.80470014 |
| 69 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.79259563 |
| 70 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.78598906 |
| 71 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.77738804 |
| 72 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.76804307 |
| 73 | Bladder cancer_Homo sapiens_hsa05219 | 0.76503670 |
| 74 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.76419071 |
| 75 | Alcoholism_Homo sapiens_hsa05034 | 0.75409926 |
| 76 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.75302721 |
| 77 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.73125979 |
| 78 | HTLV-I infection_Homo sapiens_hsa05166 | 0.73061376 |
| 79 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.70841109 |
| 80 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.70759508 |
| 81 | Hepatitis B_Homo sapiens_hsa05161 | 0.70248949 |
| 82 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.69428872 |
| 83 | Basal transcription factors_Homo sapiens_hsa03022 | 0.69031524 |
| 84 | Retinol metabolism_Homo sapiens_hsa00830 | 0.68063361 |
| 85 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.67729190 |
| 86 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.66211838 |
| 87 | Influenza A_Homo sapiens_hsa05164 | 0.62071458 |
| 88 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.60438806 |
| 89 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.57543788 |
| 90 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.57468070 |
| 91 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.57336442 |
| 92 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.57255765 |
| 93 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.56669111 |
| 94 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.55426491 |
| 95 | Metabolic pathways_Homo sapiens_hsa01100 | 0.55421021 |
| 96 | Galactose metabolism_Homo sapiens_hsa00052 | 0.55096247 |
| 97 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.55063361 |
| 98 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.54046160 |
| 99 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.53840763 |
| 100 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.52443752 |
| 101 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.51981290 |
| 102 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.50794449 |
| 103 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.50624541 |
| 104 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.50207877 |
| 105 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.49620982 |
| 106 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.47740136 |
| 107 | Tuberculosis_Homo sapiens_hsa05152 | 0.47526206 |
| 108 | Lysosome_Homo sapiens_hsa04142 | 0.47466172 |
| 109 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.47383156 |
| 110 | Alzheimers disease_Homo sapiens_hsa05010 | 0.47366354 |
| 111 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.46868653 |
| 112 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.46175905 |
| 113 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.44937182 |
| 114 | Legionellosis_Homo sapiens_hsa05134 | 0.44384928 |
| 115 | Histidine metabolism_Homo sapiens_hsa00340 | 0.43003245 |
| 116 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.42653428 |
| 117 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.41930897 |
| 118 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.41279001 |
| 119 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.40278508 |
| 120 | Thyroid cancer_Homo sapiens_hsa05216 | 0.39960553 |
| 121 | Parkinsons disease_Homo sapiens_hsa05012 | 0.38988993 |
| 122 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.37612323 |
| 123 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.37104872 |
| 124 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.37027246 |
| 125 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.36130737 |
| 126 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.35344806 |
| 127 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.34648052 |
| 128 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.33690666 |
| 129 | Measles_Homo sapiens_hsa05162 | 0.33603966 |
| 130 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.31878936 |
| 131 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.30331154 |
| 132 | Apoptosis_Homo sapiens_hsa04210 | 0.26333131 |
| 133 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.25434392 |
| 134 | Protein export_Homo sapiens_hsa03060 | 0.24514177 |
| 135 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.23640591 |
| 136 | Huntingtons disease_Homo sapiens_hsa05016 | 0.23335446 |
| 137 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.21718120 |
| 138 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.21421946 |

